7
Total investments
1
Early stage
0
Mid stage
0
Late stage
5y
Years active
Portfolio
5 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board / Investor
Jun 2025
TALICA is a national platform of specialized operating companies delivering metal surface treatment, high-purity & precision cleaning, fabrication, and repair services for mission-critical, highly regulated industries.
We support aerospace, semiconductor, biotechnology, pharmaceutical, medical device, data center, water treatment, and other high-performance markets through disciplined process control and reliable execution, both on-site and in shop facilities nationwide.
TALICAs capabilities span chemical processing, high-purity system services, and complex component finishing, including:
• Passivation, derouging, sanitization, oxygen cleaning, system flushing
• Electropolishing, mechanical polishing, anodizing, hardcoat, chemfilm, black oxide
• ASME / NBBI fabrication and repairs, high-purity piping, specialty systems
• NDE / NDT inspections, pressure & leak testing
TALICAs companies are approved suppliers to leading aerospace manufacturers, biotechnology and pharmaceutical companies, semiconductor fabs, prime government contractors, and advanced industrial organizations across North America.
With AS9100, NADCAP, ISO, ASME / NBBI Stamps, ASTM, ITAR, NIST SP800-171, OSHA and FDA-regulated approvals and compliance across the platform, TALICA delivers precision and schedule certainty where performance matters most.
Board / Investor
Jun 2023
Allucent is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. The company is purpose-built through the convergence of leading providers to address this unmet need. Today, Allucent is a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics and clinical pharmacology across a variety of therapeutic areas. With more than 30 years of experience in over 60 countries, Allucent’s individualized partnership approach provides experience-driven insights and expertise to assist its clients in successfully navigating the complexities of delivering novel treatments to patients.
Board / Investor
Jun 2023
Repario is a global, end-to-end eDiscovery service team. We offer a comprehensive suite of services to help our clients navigate the complex world of electronic discovery. Our experienced professionals have the expertise and knowledge to handle every aspect of eDiscovery, from data collection and processing to document review and production. In addition to our technical expertise, we offer various consulting services to help our clients develop and implement effective eDiscovery strategies. For more information, please visit www.repariodata.com.
Board / Investor
Jun 2023
EVERSANA® is a leading independent provider of global services to the life sciences industry. The company’s integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. The company serves more than 650 organizations, including innovative start-ups and established pharmaceutical companies, to advance life sciences solutions for a healthier world. To learn more about EVERSANA, visit eversana.com.
Board / Investor
Jun 2023
Point Blank Enterprises, Inc. (PBE) is the worldwide leader in the development, manufacturing and distribution of high-performance protective solutions for the U.S. military and Department of Defense, federal agencies and both domestic and international law enforcement and corrections professionals. The Company has the strongest portfolio of product brands in the industry including Point Blank Body Armor, Protective Products, PACA and PARACLETE®. We are committed to producing the most technologically advanced ballistic systems that not only offer superior protection but also optimum comfort in the most challenging environments. With two state-of-the-art manufacturing facilities in Florida, we consistently deliver the highest quality body-armor systems in the world by driving innovation and continuously exceeding customer expectations. WE SAVE LIVES.
Experience · 12 entries
All (12)
Investments (7)
Founder (1)
2025
Board / Investor
Jun 2025
TALICA is a national platform of specialized operating companies delivering metal surface treatment, high-purity & precision cleaning, fabrication, and repair services for mission-critical, highly regulated industries.
We support aerospace, semiconductor, biotechnology, pharmaceutical, medical device, data center, water treatment, and other high-performance markets through disciplined process control and reliable execution, both on-site and in shop facilities nationwide.
TALICAs capabilities span chemical processing, high-purity system services, and complex component finishing, including:
• Passivation, derouging, sanitization, oxygen cleaning, system flushing
• Electropolishing, mechanical polishing, anodizing, hardcoat, chemfilm, black oxide
• ASME / NBBI fabrication and repairs, high-purity piping, specialty systems
• NDE / NDT inspections, pressure & leak testing
TALICAs companies are approved suppliers to leading aerospace manufacturers, biotechnology and pharmaceutical companies, semiconductor fabs, prime government contractors, and advanced industrial organizations across North America.
With AS9100, NADCAP, ISO, ASME / NBBI Stamps, ASTM, ITAR, NIST SP800-171, OSHA and FDA-regulated approvals and compliance across the platform, TALICA delivers precision and schedule certainty where performance matters most.
2023
Vice President
Dec 2023
JLL Partners is a middle market private equity firm with over three decades of experience transforming businesses in the healthcare, specialty industrials, and business services sectors. The firm is dedicated to partnering with companies that it can help build into market leaders through a combination of strategic mergers and acquisitions, organic growth initiatives, and operational enhancements. The JLL Partners team is comprised of seasoned investment professionals and operating partners who are focused on driving long-term value creation across its portfolio. Since its founding in 1988, JLL Partners has committed over $5.8 billion of equity capital across eight private equity funds, with over 55 platform investments and more than 210 add-on acquisitions.
Board / Investor
Jun 2023
Allucent is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. The company is purpose-built through the convergence of leading providers to address this unmet need. Today, Allucent is a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics and clinical pharmacology across a variety of therapeutic areas. With more than 30 years of experience in over 60 countries, Allucent’s individualized partnership approach provides experience-driven insights and expertise to assist its clients in successfully navigating the complexities of delivering novel treatments to patients.
Board / Investor
Jun 2023
Repario is a global, end-to-end eDiscovery service team. We offer a comprehensive suite of services to help our clients navigate the complex world of electronic discovery. Our experienced professionals have the expertise and knowledge to handle every aspect of eDiscovery, from data collection and processing to document review and production. In addition to our technical expertise, we offer various consulting services to help our clients develop and implement effective eDiscovery strategies. For more information, please visit www.repariodata.com.
Board / Investor
Jun 2023
EVERSANA® is a leading independent provider of global services to the life sciences industry. The company’s integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. The company serves more than 650 organizations, including innovative start-ups and established pharmaceutical companies, to advance life sciences solutions for a healthier world. To learn more about EVERSANA, visit eversana.com.
Show all 12 entries ↓
Investment activity
2021–2025 · 7 investments
Recent (last 2 years)Earlier